U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT06848374) titled 'Dose Efficacy in Adhesive Capsulitis' on Feb. 08.
Brief Summary: The purpose of this study is to find out if the treatment of adhesive capsulitis with 40 mg of methylprednisolone in combination with a hydrodilatation is comparable to 80 mg of methylprednisolone for pain reduction, improving shoulder mobility, and reducing side effects.
Researchers will enroll 40 people in this study which is taking place solely at the Toronto Rehabilitation Institute, University Avenue. This study should take approximately 12 months to complete and the results should be known in about 15 to 18 months. During this study, patients will receive an ult...